SCHEMBL3316713

SCHEMBL3316713

CC(C)(C)OC(=O)N1CCC[C@@H](C(=O)OC(=O)[C@@H]2CCCN(C(=O)OC(C)(C)C)C2)C1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.63
MEN1 O00255 1/20 0.63
MAPT P10636 1/20 0.63
KMT2A Q03164 1/20 0.63
HPGD P15428 1/20 0.57
EPHX1 P07099 1/20 0.48
RECQL P46063 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ABL1 P00519 1/20 0.43
RIN1 Q13671 1/20 0.43
HSD11B1 P28845 1/20 0.43
PREP P48147 1/20 0.43
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GLS O94925 1/20 0.42
USP30 Q70CQ3 1/20 0.42
BACE1 P56817 2/20 0.41
CTSD P07339 1/20 0.41
NR1H2 P55055 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9882415 0.89 ALDH1A1 (0.61) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL641371 0.89 ALDH1A1 (0.61) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL641372 0.89 ALDH1A1 (0.61) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL3316718 0.88 MAPT (0.52) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL13295633 0.88 MEN1 (0.63) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL27709430 0.87 MEN1 (0.66) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL28097167 0.87 MEN1 (0.66) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL3608462 0.86 MEN1 (0.68) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL40057 0.86 MEN1 (0.64) ALDH1A1MEN1MAPTKMT2AHPGD
SCHEMBL181768 0.86 MEN1 (0.64) ALDH1A1MEN1MAPTKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2123769-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF KANEKA CORP (JP) 2016-05-18 EP disclosed
US-20150166481-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF KANEKA CORPORATION (JP) 2015-06-18 US disclosed
US-20130079525-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF KANEKA CORPORATION (JP) 2013-03-28 US disclosed
US-8338142-B2 Method for producing optically active 3-aminopiperidine or salt thereof KANEKA CORPORATION (JP) 2012-12-25 US disclosed
US-20100105917-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF KANEKA CORPORATION (JP) 2010-04-29 US disclosed
EP-2123769-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF Kaneka Corporation (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079525-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF NPEPPS, APEH, DNPEP ALDH1A1 1293/4885MEN1 3450/4885MAPT 4470/4885
US-20100105917-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF NPEPPS, APEH, DNPEP ALDH1A1 1293/4885MEN1 3450/4885MAPT 4470/4885
US-20150166481-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF NPEPPS, APEH, DNPEP ALDH1A1 1293/4885MEN1 3450/4885MAPT 4470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.